Testing effectiveness (Phase 2)Study completedNCT06027229
What this trial is testing
Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations
Who this might be right for
ImmunosuppressionCOVID-19
University of Wisconsin, Madison 21